Literature DB >> 11748744

Analysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.

P Pastor1, E Muñoz, M Ezquerra, V Obach, M J Martí, F Valldeoriola, E Tolosa, R Oliva.   

Abstract

Missense mutations of the alpha-synuclein gene have been reported to explain a few kindreds with autosomal dominant Parkinson's disease (PD). In order to identify mutations in our PD patients, we have screened the coding region and 5'flanking region of the gene. DNA samples from 50 patients with familial PD were screened via single-strand conformation polymorphism (SSCP) for mutations in the alpha-synuclein gene. The 5' flanking region was examined in 117 additional PD patients (27 patients with unclear family history for PD, and 90 patients without family history) and in 169 control subjects. We found one change (G199A) in exon 4 in one family with a pattern of autosomal dominant PD. However, this mutation did not result in an amino acid substitution (valine) and did not segregate completely with PD. The analysis of the 5' flanking region also showed a new polymorphism, a nucleotide insertion (- 164insA) linked to a nucleotide substitution (C-116G), in patients and in controls. The -164insA/C-116G allele was present in 52.3% of the patients and in 47.6% of the controls. We did not find significant differences regarding the allelic and genotype frequencies between PD and control groups. These results suggest that mutations in the alpha-synuclein gene are a very rare cause of familial PD and that the novel -164insA/C-116G polymorphism in the 5' flanking region does not confer susceptibility to develop PD. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748744     DOI: 10.1002/mds.1198

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

1.  A search for SNCA 3' UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; René Ribacoba; Oswaldo Lorenzo-Betancor; Pau Pastor; Lluis Samaranch; Ignacio F Mata; Marta Díaz; Germán Moris; Manuel Menéndez; Ana I Corao; Victoria Alvarez
Journal:  J Mol Neurosci       Date:  2011-11-11       Impact factor: 3.444

Review 2.  Genetics of Parkinson disease.

Authors:  Nathan Pankratz; Tatiana Foroud
Journal:  NeuroRx       Date:  2004-04

3.  Lipase regulation of cellular fatty acid homeostasis as a Parkinson's disease therapeutic strategy.

Authors:  Saranna Fanning; Haley Cirka; Jennifer L Thies; Jooyoung Jeong; Sarah M Niemi; Joon Yoon; Gary P H Ho; Julian A Pacheco; Ulf Dettmer; Lei Liu; Clary B Clish; Kevin J Hodgetts; John N Hutchinson; Christina R Muratore; Guy A Caldwell; Kim A Caldwell; Dennis Selkoe
Journal:  NPJ Parkinsons Dis       Date:  2022-06-09

4.  Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

Authors:  Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl Halter; Alice Rudolph; Cliff Shults; P Michael Conneally; Tatiana Foroud
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

5.  Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease.

Authors:  A González-Pérez; J Gayán; J Marín; J J Galán; M E Sáez; L M Real; C Antúnez; A Ruiz
Journal:  Neurogenetics       Date:  2009-01-21       Impact factor: 2.660

Review 6.  Impact of gene mutation in the development of Parkinson's disease.

Authors:  Suganya Selvaraj; Shanmughavel Piramanayagam
Journal:  Genes Dis       Date:  2019-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.